Evidence map›Paper›PMID 29351447›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2018

Cigarette smoke dampens antiviral signaling in small airway epithelial cells by disrupting TLR3 cleavage.

Parker F Duffney, Claire E McCarthy, Aitor Nogales, Thomas H Thatcher, Luis Martinez-Sobrido, Richard P Phipps, Patricia J Sime

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Protocol for differentiating primary human small airway epithelial cells at the air-liquid interface.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Coinfection with influenza virus and non-typeableFrontiers in microbiology · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Results of the Adult COVID-19 Lifestyle Matching Study.International journal of public health · 2022
    Article
  13. Review
  14. Review
  15. Smoking and COVID-19: The Real Deal.Annals of the American Thoracic Society · 2021
    Article
  16. Factors influencing the immunogenicity of influenza vaccines.Human vaccines & immunotherapeutics · 2021
    Review
  17. Review
  18. Smoking and COVID-19: What we know so far.Respiratory medicine · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Parker F DuffneyDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
Claire E McCarthyDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
Aitor NogalesDepartment of Microbiology and Immunology, University of Rochester , Rochester, New York.
Thomas H ThatcherLung Biology and Disease Program, University of Rochester School of Medicine and Dentistry , Rochester, New York.ORCID 0000-0001-7177-3041
Luis Martinez-SobridoDepartment of Microbiology and Immunology, University of Rochester , Rochester, New York.
Richard P PhippsDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
Patricia J SimeDepartment of Environmental Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York.
University of Rochester · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
The University of Rochester's Clinical and Translational Science InstituteUL1TR002001 · NCATS · UNIVERSITY OF ROCHESTER · PI WILSON, KAREN M., ZAND, MARTIN S · 2016 to 2024
$34.6M
Training in Environment ToxicologyT32ES007026 · NIEHS · UNIVERSITY OF ROCHESTER · PI Alison Elder, Marissa Sobolewski Terry · 1985 to 2026
$20.2M
MULTIDISCIPLINARY TRAINING IN PULMONARY RESEARCHT32HL066988 · NHLBI · UNIVERSITY OF ROCHESTER · PI GEORAS, STEVE N, O'REILLY, MICHAEL A · 2001 to 2021
$8.1M
Novel therapies for cigarette smoke induced lung injuryR01HL120908 · NHLBI · UNIVERSITY OF ROCHESTER · PI SIME, PATRICIA JANET · 2014 to 2017
$1.6M
NCATS NIH HHS UL1 TR002001NHLBI NIH HHS R01 HL120908NHLBI NIH HHS T32 HL066988NIEHS NIH HHS P30 ES001247NIEHS NIH HHS T32 ES007026
6 · The paper itself

Abstract

Cigarette smokers and people exposed to second-hand smoke are at an increased risk for pulmonary viral infections, and yet the mechanism responsible for this heightened susceptibility is not understood. To understand the effect of cigarette smoke on susceptibility to viral infection, we used an air-liquid interface culture system and exposed primary human small airway epithelial cells (SAEC) to whole cigarette smoke, followed by treatment with the viral mimetic polyinosinic polycytidylic acid (poly I:C) or influenza A virus (IAV). We found that prior smoke exposure strongly inhibited production of proinflammatory (interleukin-6 and interleukin-8) and antiviral [interferon-γ-induced protein 10 (IP-10) and interferons] mediators in SAECs in response to poly I:C and IAV infection. Impaired antiviral responses corresponded to increased infection with IAV. This was associated with a decrease in phosphorylation of the key antiviral transcription factor interferon response factor 3 (IRF3). Here, we found that cigarette smoke exposure inhibited activation of Toll-like receptor 3 (TLR3) by impairing TLR3 cleavage, which was required for downstream phosphorylation of IRF3 and production of IP-10. These results identify a novel mechanism by which cigarette smoke exposure impairs antiviral responses in lung epithelial cells, which may contribute to increased susceptibility to respiratory infections.

Indexed as

Antiviral AgentsCells, CulturedEpithelial CellsHumansInfluenza A virusInfluenza, HumanInterferon-betaPoly I-CRespiratory SystemSignal TransductionSmokingToll-Like Receptor 3Antiviral AgentsInterferon-betaPoly I-CTLR3 protein, humanToll-Like Receptor 3chronic obstructive pulmonary diseasecigarette smokelung epitheliumToll-like receptor 3viral mimetic polyinosinic polycytidylic acid

Identifiers

PMID29351447
PMCPMC5900359
OpenAlexW2777441678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.